We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.16B
AUM Growth
+$73.7M
(+6.8%)
Cap. Flow
+$24.1M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
208
New
17
Increased
35
Reduced
30
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$29.5M |
| 2 |
Arcus Biosciences
RCUS
|
+$20.6M |
| 3 |
Revolution Medicines
RVMD
|
+$17.5M |
| 4 |
AFIB
Acutus Medical Inc
AFIB
|
+$16.2M |
| 5 |
American Well
AMWL
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$27.4M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$25.1M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$20.5M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$17.1M |
| 5 |
Health Catalyst
HCAT
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.35% |
| 2 | Industrials | 4.01% |
| 3 | Technology | 0.1% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$119B
| $2.69M | 0.23% |
9,871
-4,800
| -33% | -$1.32M |
|
|
MTEM
77
DELISTED
Molecular Templates, Inc.
MTEM
| $1.96M | 0.17% |
11,967
-27,711
| -70% | -$4.93M |
|
78
Danaher
DHR
$139B
| $1.61M | 0.14% |
+8,460
| New | +$1.5M |
|
79
Illumina
ILMN
$29.9B
| $1.5M | 0.13% |
4,981
+2,175
| +78% | +$749K |
|
|
TRHC
80
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.43M | 0.12% |
35,177
-279,713
| -89% | -$13.9M |
|
|
CHNG
81
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $1.19M | 0.1% |
82,145
-1,344,687
| -94% | -$17.1M |
|
82
Humana
HUM
$45B
| $1.1M | 0.09% |
2,666
-2,559
| -49% | -$1.03M |
|
|
GBIO
83
DELISTED
Generation Bio
GBIO
| $1.08M | 0.09% |
3,500
-47,630
| -93% | -$11.4M |
|
84
Castle Biosciences
CSTL
$928M
| $952K | 0.08% |
18,500
-125,000
| -87% | -$5.56M |
|
85
argenx
ARGX
$52B
| $656K | 0.06% |
2,500
| – | – |
|
|
AVEO
86
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $594K | 0.05% |
100,000
-50,000
| -33% | -$247K |
|
87
Dr. Reddy's Laboratories
RDY
$10.1B
| $372K | 0.03% |
26,770
-10,000
| -27% | -$119K |
|
88
Zai Lab
ZLAB
$2.05B
| $225K | 0.02% |
2,700
-4,100
| -60% | -$329K |
|
89
Agios Pharmaceuticals
AGIO
$1.82B
| – | – |
-9,400
| Closed | -$503K |
|
90
Alkermes
ALKS
$8.31B
| – | – |
-24,300
| Closed | -$472K |
|
|
ALLK
91
DELISTED
Allakos
ALLK
| – | – |
-3,700
| Closed | -$266K |
|
92
Allogene Therapeutics
ALLO
$635M
| – | – |
-7,400
| Closed | -$317K |
|
93
Alnylam Pharmaceuticals
ALNY
$29.5B
| – | – |
-17,600
| Closed | -$2.61M |
|
94
Amneal Pharmaceuticals
AMRX
$6.02B
| – | – |
-17,700
| Closed | -$84K |
|
|
APLS
95
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-768,609
| Closed | -$25.1M |
|
96
Arrowhead Research
ARWR
$12.1B
| – | – |
-15,300
| Closed | -$661K |
|
|
AVNS
97
DELISTED
Avanos Medical
AVNS
| – | – |
-7,300
| Closed | -$215K |
|
98
Avantor
AVTR
$9.25B
| – | – |
-63,500
| Closed | -$1.08M |
|
99
Axsome Therapeutics
AXSM
$10.9B
| – | – |
-4,200
| Closed | -$346K |
|
100
AstraZeneca
AZN
$245B
| – | – |
-70,900
| Closed | -$7.5M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
TGM
BIS
Sectoral Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Sectoral Asset Management held 208 positions worth $1.16B, up 6.8% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Sectoral Asset Management's Q3 2020 filing shows 17 new, 35 increased, 30 reduced and 120 closed positions. Its largest new stake was Arcus Biosciences: 922,800 shares worth $15.8M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $27.4M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
- Sectoral Asset Management's largest Q3 2020 buy was Arcus Biosciences: 922,800 shares worth $15.8M.
- Sectoral Asset Management added most to Labcorp in Q3 2020, an estimated $29.5M increase.
- Sectoral Asset Management's biggest Q3 2020 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $17.1M.
- Sectoral Asset Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2020, selling an estimated $27.4M.
- Sectoral Asset Management's ten largest holdings make up 28% of its $1.16B portfolio in Q3 2020.
- Sectoral Asset Management opened 17 new positions and closed 120 in Q3 2020.
- Sectoral Asset Management's portfolio value rose 6.8% quarter-over-quarter to $1.16B.
Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.